Medical Care

Global Biologics Drug Development Market Research Report 2025

This report aims to provide a comprehensive presentation of the global market for Biologics Drug Development, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biologics Drug Development.
The Biologics Drug Development market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Biologics Drug Development market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biologics Drug Development companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbvie
Allergan
Boehringer Ingelheim
Charles River Laboratories
Catalent
Lonza Group
Amgen
Sanofi
Segment by Type
Clinical Manufacturing
Formulation Development
Bioassay Development
Analytical Services
Segment by Application
In-House
Outsource
Pharma Excess
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Biologics Drug Development company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biologics Drug Development Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Clinical Manufacturing
1.2.3 Formulation Development
1.2.4 Bioassay Development
1.2.5 Analytical Services
1.3 Market by Application
1.3.1 Global Biologics Drug Development Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 In-House
1.3.3 Outsource
1.3.4 Pharma Excess
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Biologics Drug Development Market Perspective (2020-2031)
2.2 Global Biologics Drug Development Growth Trends by Region
2.2.1 Global Biologics Drug Development Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Biologics Drug Development Historic Market Size by Region (2020-2025)
2.2.3 Biologics Drug Development Forecasted Market Size by Region (2026-2031)
2.3 Biologics Drug Development Market Dynamics
2.3.1 Biologics Drug Development Industry Trends
2.3.2 Biologics Drug Development Market Drivers
2.3.3 Biologics Drug Development Market Challenges
2.3.4 Biologics Drug Development Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biologics Drug Development Players by Revenue
3.1.1 Global Top Biologics Drug Development Players by Revenue (2020-2025)
3.1.2 Global Biologics Drug Development Revenue Market Share by Players (2020-2025)
3.2 Global Biologics Drug Development Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Biologics Drug Development Revenue
3.4 Global Biologics Drug Development Market Concentration Ratio
3.4.1 Global Biologics Drug Development Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biologics Drug Development Revenue in 2024
3.5 Global Key Players of Biologics Drug Development Head office and Area Served
3.6 Global Key Players of Biologics Drug Development, Product and Application
3.7 Global Key Players of Biologics Drug Development, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Biologics Drug Development Breakdown Data by Type
4.1 Global Biologics Drug Development Historic Market Size by Type (2020-2025)
4.2 Global Biologics Drug Development Forecasted Market Size by Type (2026-2031)
5 Biologics Drug Development Breakdown Data by Application
5.1 Global Biologics Drug Development Historic Market Size by Application (2020-2025)
5.2 Global Biologics Drug Development Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Biologics Drug Development Market Size (2020-2031)
6.2 North America Biologics Drug Development Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Biologics Drug Development Market Size by Country (2020-2025)
6.4 North America Biologics Drug Development Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Biologics Drug Development Market Size (2020-2031)
7.2 Europe Biologics Drug Development Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Biologics Drug Development Market Size by Country (2020-2025)
7.4 Europe Biologics Drug Development Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Biologics Drug Development Market Size (2020-2031)
8.2 Asia-Pacific Biologics Drug Development Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Biologics Drug Development Market Size by Region (2020-2025)
8.4 Asia-Pacific Biologics Drug Development Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Biologics Drug Development Market Size (2020-2031)
9.2 Latin America Biologics Drug Development Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Biologics Drug Development Market Size by Country (2020-2025)
9.4 Latin America Biologics Drug Development Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biologics Drug Development Market Size (2020-2031)
10.2 Middle East & Africa Biologics Drug Development Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Biologics Drug Development Market Size by Country (2020-2025)
10.4 Middle East & Africa Biologics Drug Development Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbvie
11.1.1 Abbvie Company Details
11.1.2 Abbvie Business Overview
11.1.3 Abbvie Biologics Drug Development Introduction
11.1.4 Abbvie Revenue in Biologics Drug Development Business (2020-2025)
11.1.5 Abbvie Recent Development
11.2 Allergan
11.2.1 Allergan Company Details
11.2.2 Allergan Business Overview
11.2.3 Allergan Biologics Drug Development Introduction
11.2.4 Allergan Revenue in Biologics Drug Development Business (2020-2025)
11.2.5 Allergan Recent Development
11.3 Boehringer Ingelheim
11.3.1 Boehringer Ingelheim Company Details
11.3.2 Boehringer Ingelheim Business Overview
11.3.3 Boehringer Ingelheim Biologics Drug Development Introduction
11.3.4 Boehringer Ingelheim Revenue in Biologics Drug Development Business (2020-2025)
11.3.5 Boehringer Ingelheim Recent Development
11.4 Charles River Laboratories
11.4.1 Charles River Laboratories Company Details
11.4.2 Charles River Laboratories Business Overview
11.4.3 Charles River Laboratories Biologics Drug Development Introduction
11.4.4 Charles River Laboratories Revenue in Biologics Drug Development Business (2020-2025)
11.4.5 Charles River Laboratories Recent Development
11.5 Catalent
11.5.1 Catalent Company Details
11.5.2 Catalent Business Overview
11.5.3 Catalent Biologics Drug Development Introduction
11.5.4 Catalent Revenue in Biologics Drug Development Business (2020-2025)
11.5.5 Catalent Recent Development
11.6 Lonza Group
11.6.1 Lonza Group Company Details
11.6.2 Lonza Group Business Overview
11.6.3 Lonza Group Biologics Drug Development Introduction
11.6.4 Lonza Group Revenue in Biologics Drug Development Business (2020-2025)
11.6.5 Lonza Group Recent Development
11.7 Amgen
11.7.1 Amgen Company Details
11.7.2 Amgen Business Overview
11.7.3 Amgen Biologics Drug Development Introduction
11.7.4 Amgen Revenue in Biologics Drug Development Business (2020-2025)
11.7.5 Amgen Recent Development
11.8 Sanofi
11.8.1 Sanofi Company Details
11.8.2 Sanofi Business Overview
11.8.3 Sanofi Biologics Drug Development Introduction
11.8.4 Sanofi Revenue in Biologics Drug Development Business (2020-2025)
11.8.5 Sanofi Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Biologics Drug Development Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Clinical Manufacturing
Table 3. Key Players of Formulation Development
Table 4. Key Players of Bioassay Development
Table 5. Key Players of Analytical Services
Table 6. Global Biologics Drug Development Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Biologics Drug Development Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Biologics Drug Development Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Biologics Drug Development Market Share by Region (2020-2025)
Table 10. Global Biologics Drug Development Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Biologics Drug Development Market Share by Region (2026-2031)
Table 12. Biologics Drug Development Market Trends
Table 13. Biologics Drug Development Market Drivers
Table 14. Biologics Drug Development Market Challenges
Table 15. Biologics Drug Development Market Restraints
Table 16. Global Biologics Drug Development Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Biologics Drug Development Market Share by Players (2020-2025)
Table 18. Global Top Biologics Drug Development Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biologics Drug Development as of 2024)
Table 19. Ranking of Global Top Biologics Drug Development Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Biologics Drug Development Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Biologics Drug Development, Headquarters and Area Served
Table 22. Global Key Players of Biologics Drug Development, Product and Application
Table 23. Global Key Players of Biologics Drug Development, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Biologics Drug Development Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Biologics Drug Development Revenue Market Share by Type (2020-2025)
Table 27. Global Biologics Drug Development Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Biologics Drug Development Revenue Market Share by Type (2026-2031)
Table 29. Global Biologics Drug Development Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Biologics Drug Development Revenue Market Share by Application (2020-2025)
Table 31. Global Biologics Drug Development Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Biologics Drug Development Revenue Market Share by Application (2026-2031)
Table 33. North America Biologics Drug Development Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Biologics Drug Development Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Biologics Drug Development Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Biologics Drug Development Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Biologics Drug Development Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Biologics Drug Development Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Biologics Drug Development Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Biologics Drug Development Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Biologics Drug Development Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Biologics Drug Development Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Biologics Drug Development Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Biologics Drug Development Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Biologics Drug Development Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Biologics Drug Development Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Biologics Drug Development Market Size by Country (2026-2031) & (US$ Million)
Table 48. Abbvie Company Details
Table 49. Abbvie Business Overview
Table 50. Abbvie Biologics Drug Development Product
Table 51. Abbvie Revenue in Biologics Drug Development Business (2020-2025) & (US$ Million)
Table 52. Abbvie Recent Development
Table 53. Allergan Company Details
Table 54. Allergan Business Overview
Table 55. Allergan Biologics Drug Development Product
Table 56. Allergan Revenue in Biologics Drug Development Business (2020-2025) & (US$ Million)
Table 57. Allergan Recent Development
Table 58. Boehringer Ingelheim Company Details
Table 59. Boehringer Ingelheim Business Overview
Table 60. Boehringer Ingelheim Biologics Drug Development Product
Table 61. Boehringer Ingelheim Revenue in Biologics Drug Development Business (2020-2025) & (US$ Million)
Table 62. Boehringer Ingelheim Recent Development
Table 63. Charles River Laboratories Company Details
Table 64. Charles River Laboratories Business Overview
Table 65. Charles River Laboratories Biologics Drug Development Product
Table 66. Charles River Laboratories Revenue in Biologics Drug Development Business (2020-2025) & (US$ Million)
Table 67. Charles River Laboratories Recent Development
Table 68. Catalent Company Details
Table 69. Catalent Business Overview
Table 70. Catalent Biologics Drug Development Product
Table 71. Catalent Revenue in Biologics Drug Development Business (2020-2025) & (US$ Million)
Table 72. Catalent Recent Development
Table 73. Lonza Group Company Details
Table 74. Lonza Group Business Overview
Table 75. Lonza Group Biologics Drug Development Product
Table 76. Lonza Group Revenue in Biologics Drug Development Business (2020-2025) & (US$ Million)
Table 77. Lonza Group Recent Development
Table 78. Amgen Company Details
Table 79. Amgen Business Overview
Table 80. Amgen Biologics Drug Development Product
Table 81. Amgen Revenue in Biologics Drug Development Business (2020-2025) & (US$ Million)
Table 82. Amgen Recent Development
Table 83. Sanofi Company Details
Table 84. Sanofi Business Overview
Table 85. Sanofi Biologics Drug Development Product
Table 86. Sanofi Revenue in Biologics Drug Development Business (2020-2025) & (US$ Million)
Table 87. Sanofi Recent Development
Table 88. Research Programs/Design for This Report
Table 89. Key Data Information from Secondary Sources
Table 90. Key Data Information from Primary Sources
Table 91. Authors List of This Report


List of Figures
Figure 1. Biologics Drug Development Picture
Figure 2. Global Biologics Drug Development Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Biologics Drug Development Market Share by Type: 2024 VS 2031
Figure 4. Clinical Manufacturing Features
Figure 5. Formulation Development Features
Figure 6. Bioassay Development Features
Figure 7. Analytical Services Features
Figure 8. Global Biologics Drug Development Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Biologics Drug Development Market Share by Application: 2024 VS 2031
Figure 10. In-House Case Studies
Figure 11. Outsource Case Studies
Figure 12. Pharma Excess Case Studies
Figure 13. Biologics Drug Development Report Years Considered
Figure 14. Global Biologics Drug Development Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Biologics Drug Development Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Biologics Drug Development Market Share by Region: 2024 VS 2031
Figure 17. Global Biologics Drug Development Market Share by Players in 2024
Figure 18. Global Top Biologics Drug Development Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biologics Drug Development as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Biologics Drug Development Revenue in 2024
Figure 20. North America Biologics Drug Development Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Biologics Drug Development Market Share by Country (2020-2031)
Figure 22. United States Biologics Drug Development Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Biologics Drug Development Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Biologics Drug Development Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Biologics Drug Development Market Share by Country (2020-2031)
Figure 26. Germany Biologics Drug Development Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Biologics Drug Development Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Biologics Drug Development Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Biologics Drug Development Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Biologics Drug Development Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Biologics Drug Development Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Biologics Drug Development Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Biologics Drug Development Market Share by Region (2020-2031)
Figure 34. China Biologics Drug Development Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Biologics Drug Development Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Biologics Drug Development Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Biologics Drug Development Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Biologics Drug Development Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Biologics Drug Development Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Biologics Drug Development Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Biologics Drug Development Market Share by Country (2020-2031)
Figure 42. Mexico Biologics Drug Development Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Biologics Drug Development Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Biologics Drug Development Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Biologics Drug Development Market Share by Country (2020-2031)
Figure 46. Turkey Biologics Drug Development Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Biologics Drug Development Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Biologics Drug Development Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Abbvie Revenue Growth Rate in Biologics Drug Development Business (2020-2025)
Figure 50. Allergan Revenue Growth Rate in Biologics Drug Development Business (2020-2025)
Figure 51. Boehringer Ingelheim Revenue Growth Rate in Biologics Drug Development Business (2020-2025)
Figure 52. Charles River Laboratories Revenue Growth Rate in Biologics Drug Development Business (2020-2025)
Figure 53. Catalent Revenue Growth Rate in Biologics Drug Development Business (2020-2025)
Figure 54. Lonza Group Revenue Growth Rate in Biologics Drug Development Business (2020-2025)
Figure 55. Amgen Revenue Growth Rate in Biologics Drug Development Business (2020-2025)
Figure 56. Sanofi Revenue Growth Rate in Biologics Drug Development Business (2020-2025)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies